康普药业股份有限公司

Manufacturer / marketing-authorisation holder

康普药业股份有限公司 — 333 products across 1 markets, 3 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.

康普药业股份有限公司 — 333 productos en 1 mercados, 3 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.

康普药业股份有限公司 —— 共 333 个产品,覆盖 1 个市场、3 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。

333 products · 1 markets · 3 brand names

333 productos · 1 mercados · 3 marcas

333 个产品 · 1 个市场 · 3 个品牌名

Products by country

CN (333 records)

Source: code.nhsa.gov.cn

BrandActive ingredient(s)Form
—度米芬tablet
—奥美拉唑injection
—奥美拉唑capsule
—奥美拉唑capsule
—奥美拉唑capsule
—奥美拉唑capsule
—奥美拉唑capsule
—奥美拉唑capsule
—兰索拉唑tablet
—兰索拉唑tablet
—兰索拉唑tablet
—兰索拉唑tablet
—兰索拉唑tablet
—兰索拉唑tablet
—兰索拉唑tablet
—兰索拉唑tablet
—兰索拉唑tablet
—兰索拉唑tablet
—兰索拉唑tablet
—兰索拉唑tablet
—泮托拉唑钠injection
—丙谷胺tablet
—胃膜素capsule
—胃膜素capsule
—间苯三酚injection
—盐酸托烷司琼injection
—盐酸托烷司琼injection
—胆酸钠tablet
—肌苷tablet
—抗乙肝免疫核糖核酸injection
—抗乙肝免疫核糖核酸injection
—抗乙肝免疫核糖核酸injection
—盐酸小檗碱tablet
—盐酸小檗碱tablet
—盐酸小檗碱tablet
—多酶tablet
—胃蛋白酶tablet
—胰酶tablet
—胰岛素injection
—胰岛素injection
—格列吡嗪tablet
—格列吡嗪tablet
—维格列汀tablet
—维格列汀tablet
—维生素B1tablet
—维生素B1tablet
—复合维生素Btablet
—维生素Ctablet
—维生素Ctablet
—维生素Ctablet
—维生素Ctablet
—维生素Ctablet
—维生素Ctablet
—维生素B2tablet
—维生素B2tablet
—维生素B6tablet
—硫糖铝小檗碱tablet
—肝素injection
—肝素injection
—肝素injection

Showing the first 60 of 333 products (ordered by country).

Mostrando los primeros 60 de 333 productos (orden por país).

仅显示前 60 / 333 个产品(按国家排序)。

Source & licence: product rows link to the regulator record (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA); facts only — see the licence register.